Abstract
Primary cancers of the kidney are rare at any age. Although only a small proportion of cases are clearly inherited, genetic predisposition is the most important aetiological factor thus far identified in this group of tumours. The histological type of tumour depends very much on the age at tumour diagnosis; congenital mesoblastic nephroma is most common in the first 3 months of life, followed by a predominance of Wilms tumour (nephroblastoma) in early childhood which is overtaken by renal cell carcinoma in adult life. Kidney cancer is extremely rare between the ages of 7 and 40 years (see Figure 7.1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cardesa, A., Ribalta, T., Von, S.B. et al. (1989) Experimental model of tumors associated with neurofibromatosis. Cancer. 63 (9) 1737–49.
Breslow, N., Olshan, A., Beckwith, J.B. et al. (1993) Epidemiology of Wilms Tumor. Med. Pediatr. Oncol., 21 (3) 172–81.
Beckwith, J.B., Kiviat, N.B. and Bonadio, J.F. (1990) Nephrogenic rests, nephroblastomatosis and the pathogenesis of Wilms tumour. Pediatr. Pathol., 10, 1–36.
Knudson, A.G. and Strong, L.C. (1972) Mutation and cancer: a model for Wilms tumor of the kidney. J. Natl Cancer Inst., 48, 313–24.
Goodrich, D.W. and Lee, W.-H. (1990) The molecular genetics of retinoblastoma. Cancer Surv., 9, 529–54.
Maw, M., Grundy, P., Millow, L. et al. (1992) A third Wilms tumor locus on chromosome 16q. Cancer Res., 52, 3094–8.
Haber, D.A., Buckler, A.J., Glaser, T. et al. (1990) An internal deletion within a 11p13 zinc finger gene contributes to the development of Wilms tumor. Cell, 61, (7) 1257–69.
Little, M.H., Prosser, J., Condie, A. et al. (1992) Zinc finger point mutations within the WT1 gene in Wilms tumor patients. Proc. Natl Acad. Sci. USA, 89 (11) 4791–5.
Knudson, A. (1980) Genetics and the child cured of cancer, In Status of the Curability of Childhood Cancers (eds J. van Eys and M.P. Sullivan), Raven Press, New York, p. 296.
Li F., Williams, W. Gimbere, K. et al. (1988) Heritable fraction of unilateral Wilms tumour. Pediatrics, 81, 147–9.
Hawkins, M., Draper, G. and Smith, R.A. (1989) Cancer among 1,348 offspring of survivors of childhood cancer. Int. J. Cancer, 43, 975–8.
Byrne, J., Mulvihill, J., Connelly, R. et al. (1988) Reproductive problems and birth defects in survivors of Wilms tumour and their relatives. Med. Pediatr. Oncol., 16, 233–40.
Wiedemann, H.R. (1983) Tumours and hemihypetrophy associated with Wiedemann-Beckwith syndrome. Eur. J. Pediatr., 141, 129–36.
Sotelo-Avila, C, Gonzalez-Crussi, F. and Fowler, J. (1980) Complete and incomplete forms of Beckwith — Wiedemann syndrome: their oncogenic potential. J. Pediatr., 96, 47–50.
Bonaïti-Pellié, C., Chompret, A., Tournade, M.-F. et al. (1993) Excess of multifocal tumours in nephroblastoma: implications for mechanisms of tumour development and genetic counselling. Hum. Genet., 91, 373–6.
Ton, C., Hirvonen, H., Miwa, H. et al. (1991) Positional cloning and characterisation of a paired box-and homeobox-containing gene from the aniridia region. Cell, 67, 1059–74.
Gessler, M., Poustka, A. Cavenee, W. et al. (1990) Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature, 343, 774–8.
Call, K.M., Glaser, T., Ito, C.Y. et al. (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms tumor locus. Cell, 60 (3), 509–20.
Van Heyningen, V., Bickmore, W.A., Seawright, A. et al. (1990) Role for the Wilms tumor gene in genital development? Proc. Natl Acad. Sci. USA, 87 (14), 5383–6.
Baird, P.N., Groves, N., Haber, D.A. et al. (1992) Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome. Oncogene, 7 (11), 2141–9.
Brown, K.W., Watson, J.E., Poirier, V. et al. (1992) Inactivation of the remaining allele of the WT1 gene in a Wilms tumour from a WAGR patient. Oncogene, 7, 763–8.
Gessler, M., König, A., Moore, J. et al. (1993) Homozygous inactivation of WT1 in a Wilms tumor associated with the WAGR syndrome. Genes Chromosom. Cancer, 7 (3) 131–6.
Park, S., Tomlinson, G., Nisen, P. et at. (1993) Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms tumour. Cancer Res., 53, 4757–60.
Santos, A., Osorio, A.L., Baird, P.N., et al. (1993) Insertional inactivation of the WT1 gene in tumour cells from a patient with WAGR syndrome. Hum. Genet., 92 (1), 83–6.
Armstrong, J.F., Pritchard J.K., Bickmore, W. A. et al. (1993) The expression of the Wilms tumour gene, WT1, in the developing mammalian embryo. Mech. Dev., 40 (1-2), 85–97.
Pritchard-Jones, K., Fleming S., Davidson, D. et al. (1990) The candidate Wilms tumour gene is involved in genitourinary development. Nature, 346, 194–7.
Pelletier, J., Bruening, W., Kashtan, C.E., et al. (1991) Germline mutations in the Wilms tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell, 67 (2), 437–47.
Little, M., Williamson, K., Mannens, M., et al. (1993) Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion. Hum. Mol. Genet., 2 (3), 259–64.
Bruening, W., Bardeesy, N., Silverman, B. et al. (1992) Germline intronic and exonic mutations in the Wilms tumour gene (WT1) affecting urogenital development. Nature Genet., 1, 144–8.
Coppes, M.J., Campbell, C.E. and Williams, B.R. (1993) The role of WT1 in Wilms tumorigenesis. FASEB J., 7 (10), 886–95.
König, A., Jakubiczka, S., Wieacker, P. et al. (1993) Further evidence that imbalance of WT1 isoforms may be involved in Denys-Drash syndrome. Hum. Mol. Genet., 2, 1967–8.
Coppes, M., Liefers, G., Higuchi, M. et al. (1992) Inherited WT1 mutation in DDS. Cancer Res., 52, 6125–8.
Baird, P.N., Santos, A., Groves, N. et al. (1992) Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome. Hum. Mol. Genet., 1 (5), 301–5.
Baird, P. and Cowell, J. (1993) A novel zinc finger mutation in a patient with Denys-Drash syndrome. Hum. Mol. Genet., 2, 2193–4.
Schneider, S., Wildhardt, G., Ludwig, R. et al. (1993) Exon skipping due to a mutation in a donor splice site in the WT-1 gene is associated with Wilms tumor and severe genital malformations. Hum. Genet., 91 (6), 599–604.
Sakai, A., Tadokoro, K., Yanagisawa, H. et al. (1993) A novel insertional mutation of the WT1 gene in a patient with Denys-Drash syndrome. Hum. Mol Genet., 2, 1969–70.
Ogawa, O., Eccles, M, Yun, K. et al. (1993) A novel insertional mutation at the third zinc finger coding region of the WT1 gene in Denys-Drash syndrome. Hum. Mol. Genet., 2, 203–4.
Nordenskjöld, A., Friedman, E. and Anvret, M. (1994) WT1 mutations in patients with Denys-Drash syndrome: a novel mutation in exon 8 and paternal allele origin. Hum Genet., 93, 115–20.
Clarkson, P., Davies, H., Williams, D. et al. (1993) Mutational screening of the Wilms tumour gene. WT1, in males with genital abnormalities. J.Med. Genet., 30, 767–72.
Akasaka, Y., Kikuchi, H., Nagai, T. et al. (1993) A point mutation found in the WT1 gene in a sporadic Wilms tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome. FEBS Lett., 317, 39–43.
Coppes, M.J., Liefers G.J., Paul, P. et al. (1993) Homozygous somatic WT1 point mutations in sporadic unilateral Wilms tumor. Proc. Natl Acad. Sci. USA, 90 (4), 1416–19.
Huff, V., Miwa, H., Haber, D.A. et al. (1991) Evidence for WT1 point Wilms tumor (WT) gene: intragenic germinal deletion in bilateral WT. Am. J. Hum. Genet., 48 (5), 997–1003.
Tadokoro, K., Fujii, H., Ohshima, A. et al. (1992) Intragenic homozygous deletion of the WT1 gene in Wilms tumor. Oncogene, 7 (6), 1215–21.
Pelletier, J., Bruening, W., Li, F.P. et al. (1991) WT1 mutations contribute to abnormal genital system development and hereditary Wilms tumour. Nature, 353, 431–4.
Wang, Z.Y., Qiu, Q.Q., Enger, K.T. et al. (1993) A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1. Proc. Natl Acad. Sci. USA, 90, 8896–900.
Wang, Z.Y., Qiu, Q.Q. and Deuel, T.F. (1993) The Wilms tumor gene product WT1 activates or suppresses transcription through separate functional domains. J. Biol. Chem., 268 (13), 9172–5.
Kreidberg, J.A., Sariola, H., Loring, J.M. et al. (1993) WT-1 is required for early kidney development. Cell, 74 (4), 679–91.
Cowell, J.K., Wadey, R.B., Haber, D.A. et al. (1991) Structural rearrangements of the WT1 gene in Wilms tumour cells. Oncogene, 6 (4), 595–9.
Kikuchi, H., Akasaka, Y., Nagai, T. et al. (1992) Genomic changes in the WT-gene (WT1) in Wilms tumors and their correlation with histology. Am. J. Pathol, 140 (4), 781–6.
Radice, P., Pilotti, S., De, B.V. et al. (1993) Homozygous intragenic loss of the WT1 locus in a sporadic intralobar Wilms tumor [letter]. Int. J. Cancer, 55 (1), 174–6.
Ton, C.C., Huff, V., Call, K.M. et al. (1991) Smallest region of overlap in Wilms tumor deletions uniquely implicates an 11 p13 zinc finger gene as the disease locus. Genomics, 10 (1), 293–7.
Drash, A., Sherman, F., Hartman, W. et al. (1970) A syndrome of pseudohermaphroditism. Wilms tumour, hypertension and degenerative renal disease. J. Pediatr, 76, 585–93.
Denys, P., Malvaux, P., Van den Berghe, H. et al. (1967) Association d’un syndrome anatomo-pathologique de pseudohermaphrodisme masculin, d’une tumeur de Wilms, d’une nephropathie parenchymateuse et d’un mosaicisms XX/XY. Arch. Fr. Pediatr., 24, 729–39.
Jadresic, L., Bleake, J., Gordon, I. et al. (1990) Clinico-pathological review of 13 children with nephropathy, Wilms tumour and genital abnormalities (DRASH syndrome). J. Pediatr., 117, 717–25.
Hastie, N.D. (1992) Dominant negative mutations in the Wilms tumour (WT1) gene cause Denys-Drash syndrome — proof that a tumour-suppressor gene plays a crucial role in normal genitourinary development. Hum. Mol Genet., 1 (5), 293–5.
Henry, I., Hoovers, J., Barichard, F. et al. (1993) Pericentric intrachromosomal insertion responsible for recurrence of del(11)(p13p14) in a family. Genes Chromosom. Cancer, 7 (1), 57–62.
Pettenati, M.J., Haynes, J.L., Wappmer, R. et al. (1986) Wiedemann-Beckwith syndrome: presentation of clinical and psychogenetic data on 22 new cases and review of the literature. Hum. Genet., 71, 143–54.
Moutou, C, Junien, C, Henry, I. et al. (1992) Beckwith-Wiedmann syndrome: a demonstration of the mechanisms responsible for the excess of transmitting females. J. Med. Genet., 29, 217–20.
Ohlsson, R., Nyström, A., Pfeifer-Ohlsson, S. et al. (1993) IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedmann syndrome. Nature Genet. 4, 94–7.
Ogawa, O., Eccles, M.R., Szeto, J. et al. (1993) Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms tumour. Nature, 362, 749–51.
Ogawa, O., Becroft, D., Morison, I. et al. (1993) Constitutional relaxation of insulin-like growth factor II gene imprinting associated with Wilms tumour and gigantism. Nature Genet., 5, 408–12.
Dao, D., Schroeder, W.T., Chao, L. et al. (1987) Genetic mechanisms of tumor-specific loss of 11p DNA sequences in Wilms tumor. Am. J. Hum. Genet., 41, 202–17.
Hamel, B., Mannens, M. and Bökkerink, J. (1990) Perlman syndrome: a report of a case and results of molecular studies. Am. J. Hum. Genet., 45 (4), A48.
Neri, G., Martini-Neri, M., Katz, B. et al. (1984) The Perlman syndrome: familial renal dysplasia with Wilms tumor, fetal gigantism and multiple congenital anomalies. Am. J. Med. Genet., 19, 195–207.
Greenberg, F., Copeland, K. and Gresik, M. (1988) Expanding the spectrum of Perlman syndrome. Am. J. Med. Genet., 29, 773–6.
Perlman, M., Levin, M. and Witteis, B. (1975) Syndrome of fetal gigantism, renal hamartomas and nephroblastomatosis with Wilms tumour. Cancer, 35, 1212–17.
Grundy, R.G., Pritchard, J., Baraitser, M. et al. (1992) Perlman and Wiedemann-Beckwith syndromes: two distinct conditions associated with Wilms tumour. Eur. J. Pediatr., 151 (12), 895–8.
Stay, E. and Vawter, G. (1977) The relationship between nephroblastomata and neuro-fibromatosis. Cancer, 39, 2550–5.
Blatt, J., Jaffe, R., Deutsch, M. et al. (1986) Neurofibromatosis and childhood tumours. Cancer, 57, 1225–9.
Perilongo, G., Felix, C.A., Meadows, A.T. et al. (1993) Sequential development of Wilms tumor, T-cell acute lymphoblastic leukemia, medulloblastoma and myeloid leukemia in a child with type 1 neurofibromatosis: a clinical and cytogenetic case report. Leukemia, 7 (6), 912–15.
Hartley, A.L., Birch, J.M., Tricker, K. et al. (1993) Wilms tumor in the Li-Fraumeni cancer family syndrome. Cancer Genet. Cytogenet., 67 (2), 133–5.
Clericuzio, C.L. (1993) Clinical phenotypes and Wilms tumor. Med. Pediatr. Oncol., 21, 182–7.
Pastore, G., Carli, M., Lemerle, J. et al. (1988) Epidemiological features of Wilms tumour: results of studies by the International Society of Paediatric Oncology (SIOP). Med. Pediatr. Oncol., 16, 7–11.
Huff, V., Compton, D.A., Chao, L.Y. et al. (1988) Lack of linkage of familial Wilms’ tumour to chromosomal band Hp13. Nature, 336, 377–8.
Schwartz, C.E., Haber, D.A., Stanton, V.P. et al. (1991) Familial predisposition to Wilms tumor does not segregate with the WT1 gene. Genomics, 10 (4), 927–30.
Huff, V., Reeve, A.E., Leppert, M. et al. (1992) Nonlinkage of 16q markers to familial predisposition to Wilms tumor. Cancer Res., 52 (21), 6117–20.
Fantes, J., Bickmore, W., Fletcher, J. et al. (1992) Submicroscopic deletions at the WAGR locus, revealed by nonradioactive in situ hybridisation. Am. J. Hum. Genet., 51,1286–94.
Baird, P., Pritchard, J. and Cowell, J. (1994) Molecular genetic analysis of chromosome 11p in familial Wilms tumour. Br. J. Cancer, 69, 1072–7.
Olson, J., Breslow, N. and Barce, J. (1993) Cancer in twins of Wilms tumour patients. Am. J. Med. Genet., 47, 91–4.
Green, D., Breslow, N., Beckwith, J.B. et al. (1993) Screening of children with hemihypertrophy, aniridia and Beckwith-Wiedemann syndrome in patients with Wilms tumour: a report from the National Wilms Tumor Study. Med. Paediatr. Oncol, 21, 188–92.
Hawkins, M., Draper, G. and Kingston, J. (1987) Incidence of second primary tumours among childhood cancer survivors. Br. J. Cancer, 56, 339–47.
Austin, M.B., Fechner, R.E. and Roggli, V.L. (1986) Pleural malignant mesothelioma following Wilms tumour. Am. J. Clin. Pathol., 86, 227–30.
Park, S., Schalling, M., Bernard, A. et al. (1993) The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nature Genet., 4 (4), 415–20.
Pritchard-Jones, K., Renshaw, J. and King-Underwood, L. (1994) The Wilms tumour (WT1) gene is mutated in a secondary leukaemia in a WAGR patient. Hum. Molec. Genet., 3, 1633–7.
Whelan, S.L., Parkin, D.M. and Masuyer, E. (eds) (1990) Patterns of Cancer in Five Continents, vol. 102, International Agency for Research on Cancer, Lyon.
Coleman, M.P., Esteve, J., Damiecki, P. et al. (eds) (1993) Trends in Cancer Incidence and Mortality, vol. 121, IARC, Lyon.
Erlandsson, R., Boldog, F., Sumegi, J. et al. (1988) Do human renal cell carcinomas arise by a double-loss mechanism? Cancer Genet. Cytogenet., 36, 197–202.
Cohen, A.J., Li, F.P., Berg, S. et al. (1979) Hereditary renal cell carcinoma associated with a chromosomal translocation. N. Engl. J. Med., 301, 592–5.
Kovacs, G., Brusa, P. and De Riese, W. (1989) Tissue-specific expression of a constitutional 3;6 translocation: development of multiple bilateral renal cell carcinomas. Int. J. Cancer, 43, 422–7.
Yamakawa, K., Morita, R., Takahashi, E. et al. (1991) A detailed deletion mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma. Cancer Res., 51, 4707–11.
Yamakawa, K., Takahashi, E., Murata, M. et al. (1992) Detailed mapping around the breakpoint of the (3;8) translocation in familial renal cell carcinoma and FRA3B. Genomics, 14, 412–16.
Pathak, S., Strong, L.C., Ferrell, R.E. et al. (1982) Familial renal cell carcinoma with a 3; 11 chromosome translocation limited to tumour cells. Science, 217, 939–41.
Kovacs, G. and Hoene, E. (1988) Loss of der (3) in renal carcinoma cells of a patient with constitutional t(3;12). Human Genet., 78, 148–50.
Li, F.P., Decker, H.-J.H., Zbar, B. et al. (1993) Clinical and genetic studies of renal cell carcinomas in a family with a constitutional chromosome 3;8 translocation. Ann. Intern. Med., 118, 106–11.
Gnarra, J.R, Tory, K., Weng, Y. et al. (1994) Mutations of the VHL tumour suppressor gene in renal carcinoma. Nature Genet., 7, 85–9.
Shimizu, M., Yokota, J., Mori, N. et al. (1990) Introduction of a normal chromosome 3p modulates the tumorigenicity of a human renal cell carcinoma cell line YCR. Oncogene, 5, 185–94.
Kantor, A.F. (1982) Hereditary renal carcinoma and chromosomal defects. N. Engl. J. Med., 307 (22), 1403–4.
Walter, T.A., Berger, C.S. and Sandberg, A.A. (1989) The cytogenetics of renal tumours. Cancer Genet. Cytogenet., 43, 15–34.
Kovacs, G. (1993) Molecular differential pathology of renal cell tumours. Histopathology, 22, 1–8.
Morita, R., Saito, S., Ishikawa, J. et al. (1991) Common regions of deletion on chromosomes 5q, 6q and 10q in renal cell carcinoma. Cancer Res., 51, 5817–20.
Ogawa, O., Habuchi, T., Kakehi, Y. et al. (1992) Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p. Cancer Res., 52, 1881–5.
Teyssier, J., Henry, I., Dozier, C. et al. (1986) Recurrent deletion of the short arm of chromosome 3 in human renal cell carcinoma: shift of the c-raf 1 locus. J. Natl Cancer Inst., 77, 1187–94.
Maher, E.R. and Yates, J.R.W. (1991) Familial renal cell carcinoma: clinical and molecular genetic aspects. Br. J. Cancer, 63, 176–9.
Latif, F., Tory, K., Gnarra J. et al. (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science, 260, 1317–20.
Kovacs, G., Emanuel, A., Neumann, H. et al. (1993) Cytogenetics of renal cell carcinoma associated with von Hippel-Lindau disease. Genes Chromosom.,Cancer, 3, 256–62.
Gomez, M.R. (1988) Tuberous Sclerosis. 2nd edn, Raven Press, New York.
Consortium ECITS. (1993) Identification and characterisation of the tuberous sclerosis gene on chromosome 16. Cell 75, 1305–15.
Green, A. Smith, M. and Yates, J. (1994) Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nature Genet., 6, 193–6.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Pritchard-Jones, K. (1996). Wilms tumour and other genetic causes of renal cancer. In: Eeles, R.A., Ponder, B.A.J., Easton, D.F., Horwich, A. (eds) Genetic Predisposition to Cancer. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-4501-3_7
Download citation
DOI: https://doi.org/10.1007/978-1-4899-4501-3_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-412-56580-9
Online ISBN: 978-1-4899-4501-3
eBook Packages: Springer Book Archive